HOME
SEARCH
RSS FEED
SUBSCRIBE
Search Results - Therapeutics
66
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Enhancing Methotrexate Efficacy for Ectopic Pregnancy Treatment
Methotrexate (MTX) loaded polymersomes are used to preferentially deliver MTX to sites of ectopic pregnancy Background Ectopic pregnancy, abnormal pregnancy implantation at sites other than in the uterine cavity, leads to internal bleeding if not identified and treated in a timely manner, and is a major cause of maternal morbidity and mortality....
Published: 9/5/2024
|
Inventor(s):
Olena Taratula
,
Oleh Taratula
,
Maureen Baldwin
,
Leslie Myatt
,
Babak Mamnoon
Keywords(s):
Category(s):
Therapeutics
Combination therapy for the treatment of triple negative breast cancer
Summary Researchers at OHSU have discovered a novel combination therapy for triple negative breast cancer, which increases immune responses, causes tumor regression and improves survival in animal models. Technology Overview Triple negative breast cancer (TNBC) represents one of the most aggressive forms of all breast cancer subtypes with a very...
Published: 9/17/2024
|
Inventor(s):
Sanjay Malhotra
,
Lisa Coussens
,
Dhanir Tailor
,
Sushil Kumar
,
Arpit Dheeraj
Keywords(s):
Therapeutics
,
Therapeutics
- Cancer
Category(s):
Therapeutics
Inhibitors of cancer-mediated bone destruction
Summary Current drugs for bone metastases merely prevent and slow the breakdown of bone, but are ineffective in slowing the spread of cancer. The current technology is a dual-acting bone defender (DABD), which acts to prevent bone destruction while simultaneously attacking cancer’s ability to spread. Technology Overview In many cancers, especially...
Published: 5/20/2024
|
Inventor(s):
Raymond Bergan
,
Ryan Gordon
,
Abhinandan Pattanayak
Keywords(s):
Therapeutics
,
Therapeutics
- Cancer
Category(s):
Therapeutics
Covalent inhibitors of PARP-16 for cancer treatment
Summary The current technology is a selective, covalent inhibitor of PARP16 with potential therapeutic applications for the treatment of cancer. Technology Overview The poly-ADP-ribose-polymerase (PARP) family is made up of 17 enzymes in humans that are increasingly recognized as major downstream regulators of NAD+-mediated signaling in cells. PARP1...
Published: 2/12/2024
|
Inventor(s):
Michael Cohen
,
Daniel Bejan
,
Sunil Sundalam
Keywords(s):
Therapeutics
,
Therapeutics
- Cancer
Category(s):
Therapeutics
CD74 as a biomarker and therapeutic target for familial platelet (FPD) disorder
Summary Research at OHSU has identified the CD74 signaling cascade as a potential therapeutic target and diagnostic biomarker for RUNX1-mutated familial platelet disorder (FPD), which is a premalignant condition for acute myeloid leukemia. Technology Overview Current estimates suggest as many as 18,000 people may be living with RUNX1-FPD in the United...
Published: 2/27/2024
|
Inventor(s):
Anupriya Agarwal
,
Mona Mohammadhosseini
Keywords(s):
Diagnostics
,
Diagnostics - Cancer
,
Diagnostics - Other
,
Therapeutics
,
Therapeutics
- Cancer
,
Therapeutics
- Other
Category(s):
Diagnostics
,
Therapeutics
Biosynthetic Gene Cluster for the Peptide Antibiotic Enduracidin
Background The emerging and persistent threat of multidrug-resistant bacterial infections has resulted in enormous healthcare costs and poses major challenges to public health. To address the need for new antibiotics capable of combating the gowning problem of resistance, Oregon State University researchers cloned and patented the biosynthetic gene...
Published: 9/12/2024
|
Inventor(s):
T. Zabriskie
,
Xihou 希厚 Yin 银
Keywords(s):
Biomedical
,
Biotechnology
,
Medical Science & Technologies
,
pharmaceuticals
Category(s):
Therapeutics
Nanoparticle ultrasound contrast agents with high acoustic activity
Summary Contrast-enhanced ultrasound allows for low-cost minimally-invasive imaging; however, the size of typical contrast reagents prevents them from penetrating tumors thereby limiting their utility for cancer diagnostic and therapeutic purposes (theranostics). Oregon Health & Science University (OHSU) researchers have developed novel nanoparticle...
Published: 11/22/2023
|
Inventor(s):
Adem Yildirim
,
Jose Luis Montoya Mira
,
Sadik Esener
,
Stuart Ibsen
Keywords(s):
Diagnostics
,
Diagnostics - Cancer
,
Imaging
,
Imaging - Acoustic
,
Research Tools
,
Therapeutics
Category(s):
Diagnostics
,
Imaging
,
Nanoscience & Microtechnologies
,
Research Tools
,
Therapeutics
A method of enhancing cancer immunotherapies through androgen receptor modulation
Summary The current technology has the potential to enhance the effectiveness of checkpoint blockade for advanced prostate cancer patients by directly enhancing T cell function through a reduction in intrinsic androgen receptor signaling. Technology Overview In many patients with advanced cancer, immunotherapy treatments have largely failed....
Published: 9/27/2023
|
Inventor(s):
Fanny Polesso
,
Amy Moran
Keywords(s):
Therapeutics
,
Therapeutics
- Cancer
Category(s):
Therapeutics
Selective PARP11 inhibitor for the treatment of cancer
Summary The current technology is a highly selective and potent inhibitor of PARP11 that could serve as an immuno-oncology therapeutic and enhance CAR-T cell therapies. Technology Overview Recent work identified PARP11 as a key component in driving tumor microenvironments (Nature Cancer, 2022), and suppression of PARP11 augmented the therapeutic...
Published: 4/29/2024
|
Inventor(s):
Michael Cohen
,
Ilsa Kirby
Keywords(s):
Therapeutics
,
Therapeutics
- Cancer
Category(s):
Therapeutics
Photoactivatable modulation of antibody binding
Summary The current technology involves a blocking construct that has the potential to increase antibody specificity and reduce unwanted off-target effects by modulating antibody activation in a manner that is predictable, reproducible and does not require genetic modification of the antibody sequence. Technology Overview Traditional antibodies...
Published: 9/21/2023
|
Inventor(s):
Stuart Ibsen
,
Michael Brasino
Keywords(s):
Diagnostics
,
Therapeutics
Category(s):
Diagnostics
,
Therapeutics
1
2
3
4
5
6
7
Home
|
Search
|
RSS
|
Subscribe
© 2024. All Rights Reserved. Powered by
Inteum